Home/Filings/5/0001753159-26-000004
5//SEC Filing

Talasaz AmirAli 5

Accession 0001753159-26-000004

CIK 0001576280other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 5:44 PM ET

Size

9.7 KB

Accession

0001753159-26-000004

Insider Transaction Report

Form 5
Period: 2025-12-31
Talasaz AmirAli
DirectorCo-Chief Executive Officer
Transactions
  • Other

    Common Stock

    [F1]
    2025-12-312,000,24813,209 total
  • Other

    Common Stock

    [F2]
    2025-12-3182,8540 total(indirect: Shares held by Talasaz Investments, L.P.)
  • Other

    Common Stock

    [F1]
    2025-12-31+2,000,2482,000,248 total(indirect: By Trust)
  • Other

    Common Stock

    [F2]
    2025-12-31+82,8542,083,102 total(indirect: By Trust)
Footnotes (2)
  • [F1]Reflects changes in form of ownership from direct to indirect due to transfer of shares to Talasaz and Eskandari 2017 Family Trust.
  • [F2]Reflects changes in form of ownership from Talasaz Investments LP due to the transfer of shares to Talasaz and Eskandari 2017 Family Trust.
Signature
/s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz|2026-01-22

Issuer

Guardant Health, Inc.

CIK 0001576280

Entity typeother

Related Parties

1
  • filerCIK 0001753159

Filing Metadata

Form type
5
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:44 PM ET
Size
9.7 KB